Jiménez-Aliaga K, Bermejo-Bescós P, Benedí J, Martín-Aragón S.

Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells

LIFE SCIENCES 2011. 89(25-26): 939-945. Number of citations: 135

[doi:10.1016/j.lfs.2011.09.023]

Martin, SM, CRUZ JENTOFT, ALFONSO JOSÉ.

Impact of hospital admission on functional and cognitive measures in older subjects

EUROPEAN GERIATRIC MEDICINE 2011. 3: 208-212.

Gallagher P, Lang PO, Cherubini A, Topinková E, Cruz-Jentoft A, Montero Errasquín B, Mádlová P, Gasperini B, Baeyens H, Baeyens JP, Michel JP, O'Mahony D.

Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2011. 67(11): 1175-1188. Number of citations: 231

[doi:10.1007/s00228-011-1061-0]

Sánchez E, Vidán MT, Serra JA, Fernández-Avilés F, Bueno H.

Prevalence of geriatric syndromes and impact on clinical and functional outcomes in older patients with acute cardiac diseases

Heart 2011. 97(19): 1602-1606. Number of citations: 83

[doi:10.1136/hrt.2011.227504]

Pérez Menéndez-Conde C, Bermejo Vicedo T, Delgado Silveira E, Carretero Accame E.

Adverse drug reactions which provoke hospital admission.

FARMACIA HOSPITALARIA 2011. 35(5): 236-243.

[doi:10.1016/j.farma.2010.08.003]

Vidán MT, Sánchez E, Gracia Y, Marañón E, Vaquero J, Serra JA.

Causes and Effects of Surgical Delay in Patients With Hip Fracture A Cohort Study

ANNALS OF INTERNAL MEDICINE 2011. 155(4): 226-226. Number of citations: 128

[doi:10.7326/0003-4819-155-4-201108160-00006]

Ortega A, Rincón Á, Jiménez-Aliaga KL, Bermejo-Bescós P, Martín-Aragón S, Molina MT, Csákÿ AG.

Synthesis and evaluation of arylquinones as BACE1 inhibitors, beta-amyloid peptide aggregation inhibitors, and destabilizers of preformed beta-amyloid fibrils

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2011. 21(8): 2183-2187. Number of citations: 32

[doi:10.1016/j.bmcl.2011.03.023]

Mulin E, Leone E, Dujardin K, Delliaux M, Leentjens A, Nobili F, Dessi B, Tible O, Agüera-Ortiz L, Osorio RS, Yessavage J, Dachevsky D, Verhey FR, Cruz Jentoft AJ, Blanc O, Llorca PM, Robert PH.

Diagnostic criteria for apathy in clinical practice.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY 2011. 26(2): 158-165. Number of citations: 135

[doi:10.1002/gps.2508]

Piers R, Pautex S, Curiale V, Curale V, Pfisterer M, Van Nes MC, Rexach L, Ribbe M, Van Den Noortgate N.

Palliative care for the geriatric patient in Europe Survey describing the services,policies,legislation,and associations

ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE 2010. 43(6): 381-385. Number of citations: 18

[doi:10.1007/s00391-010-0149-y]

Romero C, Benedí J, Villar A, Martín-Aragón S.

Involvement of Hsp70, a stress protein, in the resistance of long-term culture of PC12 cells against sodium nitroprusside (SNP)-induced cell death

ARCHIVES OF TOXICOLOGY 2010. 84(9): 699-708. Number of citations: 12

[doi:10.1007/s00204-010-0565-1]

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M.

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

AGE AND AGEING 2010. 39(4): 412-423. Number of citations: 6795

[doi:10.1093/ageing/afq034]

Cruz-Jentoft AJ, Gutiérrez B.

Upper age limits in studies submitted to a research ethics committee.

AGING CLINICAL AND EXPERIMENTAL RESEARCH 2010. 22(2): 175-178. Number of citations: 14

[doi:10.1007/BF03324793]

Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP.

Understanding sarcopenia as a geriatric syndrome.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE 2010. 13(1): 1-7. Number of citations: 339

[doi:10.1097/MCO.0b013e328333c1c1]

Simal I, Somers A, Amrouch C, Capiau A, Cherubini A, Cruz-Jentoft AJ, Gudmundsson A, Soiza RL, O 'Mahony D, Petrovic M.

A descriptive analysis of drug-drug interactions and corresponding adverse drug reactions in multimorbid older inpatients: findings from the SENATOR trial.

EUROPEAN GERIATRIC MEDICINE . : .

[doi:10.1007/s41999-024-01025-7]

Jiménez-Domínguez C, Mateos-Nozal J, Figueroa-Lin Kí C, Rexach-Cano L.

Planificación anticipada de cuidados en residencias de mayores: a propósito de un caso.

Revista espanola de geriatria y gerontologia . 59(6): 101528-101528.

[doi:10.1016/j.regg.2024.101528]

Cerreta F, European Medicines Agency Geriatric Expert Group, CRUZ JENTOFT, ALFONSO JOSÉ.

New harmonized considerations on the evaluation instruments for baseline characterization of frailty in the European Union.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . : .

[doi:10.1111/bcp.14044]

de Agustín Sierra L, Rodríguez Salazar J, Jiménez-Muñoz AB, Molina Hernández MJ, Bermejo Bescós P, Iglesias Peinado I, García Díaz B.

Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY . : .

[doi:10.1007/s00228-020-03022-8]

O'Mahony D, Gudmundsson A, Soiza RL, Petrovic M, Jose Cruz-Jentoft A, Cherubini A, Fordham R, Byrne S, Dahly D, Gallagher P, Lavan A, Curtin D, Dalton K, Cullinan S, Flanagan E, Shiely F, Samuelsson O, Sverrisdottir A, Subbarayan S, Vandaele L, Meireson E, Montero-Errasquin B, Rexach-Cano A, Correa Perez A, Lozano-Montoya I, Vélez-Díaz-Pallarés M, Cerenzia A, Corradi S, Soledad Cotorruelo Ferreiro M, Dimitri F, Marinelli P, Martelli G, Fong Soe Khioe R, Eustace J.

Corrigendum to: Prevention of adverse drug reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR* randomized controlled clinical trial.

AGE AND AGEING . : .

[doi:10.1093/ageing/afab120]